AptaBio Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Nov '25 Nov 19, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	213,580	171,234	201,805	237,483
Market Cap Growth	4.65%	-15.15%	-15.02%	-
Enterprise Value	199,505	146,945	152,862	-
Last Close Price	7650.00	6370.00	9050.00	10650.00
Forward PE	-	78.10	78.10	78.10
PS Ratio	68.71	50.95	623.11	4911.46
PB Ratio	4.50	3.16	3.29	4.54
P/TBV Ratio	4.65	3.16	3.32	4.54
EV/Sales Ratio	64.18	43.72	471.99	-
Debt / Equity Ratio	0.18	0.14	0.23	0.01
Asset Turnover	0.04	0.04	0.00	-
Quick Ratio	1.31	1.67	65.10	16.58
Current Ratio	1.46	1.79	70.27	19.63
Return on Equity (ROE)	-51.36%	-50.84%	-21.21%	-
Return on Assets (ROA)	-15.62%	-15.24%	-14.22%	-
Return on Capital (ROIC)	-20.23%	-18.90%	-16.50%	-
Return on Capital Employed (ROCE)	-38.60%	-35.80%	-18.40%	-17.30%
Earnings Yield	-11.79%	-17.16%	-5.98%	-4.45%
FCF Yield	-7.00%	-7.24%	-7.65%	-3.32%
Buyback Yield / Dilution	-10.95%	-5.58%	-0.05%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.